Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$1.76B
Total Bought:
$349.45M
Total Sold:
$492.06M
Net Transaction:
-$142.61M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Roivant Sciences Ltd.SHS(ROIV)3,750,0003,200,000-550,000$132.71M$117.02M6.64%-$15.69M
Spyre Therapeutics, Inc.(SYRE)1,279,1341,279,1340$113.56M$113.88M6.46%+$319.8K
Erasca, Inc.(ERAS)5,250,0005,590,600+340,600$96.18M$81.96M4.65%-$14.22M
First Tracks Biotherapeutics2,032,0122,080,000+47,988$40.88M$73.72M4.18%+$32.83M
Xenon Pharmaceuticals Inc.(XENE)1,595,0001,900,374+305,374$96.27M$70.67M4.01%-$25.60M
Insmed Incorporated(INSM)650,000564,251-85,749$69.30M$64.40M3.65%-$4.90M
Alkermes plcSHS(ALKS)1,125,0001,565,000+440,000$58.94M$63.41M3.60%+$4.47M
Oruka Therapeutics, Inc.(ORKA)590,000600,000+10,000$56.15M$49.97M2.83%-$6.18M
Avalo Therapeutics, Inc.(AVTX)2,900,0003,244,861+344,861$53.59M$49.74M2.82%-$3.85M
Cytokinetics, Incorporated(CYTK)550,000750,000+200,000$46.85M$49.43M2.80%+$2.58M
Revolution Medicines, Inc.(RVMD)250,000225,000-25,000$46.82M$46.18M2.62%-$636.5K
Praxis Precision Medicines, Inc.(PRAX)185,000155,000-30,000$61.94M$45.14M2.56%-$16.80M
Belite Bio, IncADS(BLTE)165,000242,088+77,088$25.41M$41.11M2.33%+$15.70M
Celldex Therapeutics, Inc.(CLDX)700,0001,160,499+460,499$26.05M$37.61M2.13%+$11.56M
ABIVAX Société AnonymeADS(ABVX)330,000330,0000$43.98M$32.68M1.85%-$11.30M
Dianthus Therapeutics, Inc.(DNTH)400,000350,000-50,000$38.99M$30.82M1.75%-$8.17M
Odyssey Therapeutics Inc766,3461,260,000+493,654$14.34M$28.00M1.59%+$13.66M
Arrowhead Pharmaceuticals, Inc.(ARWR)150,000425,000+275,000$12.23M$27.82M1.58%+$15.59M
Trevi Therapeutics, Inc.(TRVI)1,800,1721,800,1720$33.57M$25.78M1.46%-$7.79M
Ovid Therapeutics Inc.(OVID)10,144,56210,144,5620$27.29M$25.26M1.43%-$2.03M
Sagimet Biosciences Inc.COM SER A(SGMT)2,497,8642,527,384+29,520$19.31M$24.97M1.42%+$5.66M
Lexeo Therapeutics, Inc.(LXEO)5,807,6117,245,611+1,438,000$27.03M$24.49M1.39%-$2.54M
Protagonist Therapeutics Inc172,125172,1250$21.10M$24.25M1.38%+$3.15M
Nurix Therapeutics, Inc.(NRIX)967,620967,6200$23.47M$22.94M1.30%-$532.2K
Omeros CorporationNOTE 9 500 6 1(OMER)000$12.18M$21.21M1.20%+$9.02M
Vogenx Inc0915,000+915,000$0$20.85M1.18%+$20.85M
Mineralys Therapeutics, Inc.(MLYS)750,000750,0000$20.23M$18.85M1.07%-$1.39M
Tyra Biosciences, Inc.(TYRA)200,012850,000+649,988$6.39M$18.59M1.05%+$12.20M
Sutro Biopharma, Inc.(STRO)1,172,4871,152,487-20,000$38.93M$18.57M1.05%-$20.36M
Travere Therapeutics, Inc.(TVTX)300,000300,0000$17.04M$17.66M1.00%+$621.0K
Alto Neuroscience, Inc.(ANRO)850,000643,343-206,657$22.43M$16.42M0.93%-$6.01M
Arvinas, Inc.(ARVN)02,050,000+2,050,000$0$15.86M0.90%+$15.86M
Eupraxia Pharmaceuticals Inc.(EPRX)1,650,0001,716,320+66,320$10.91M$15.62M0.89%+$4.71M
Relay Therapeutics, Inc.(RLAY)1,050,000850,000-200,000$19.65M$15.34M0.87%-$4.30M
Madrigal Pharmaceuticals, Inc.(MDGL)40,00030,000-10,000$21.48M$15.12M0.86%-$6.36M
Cullinan Therapeutics, Inc.(CGEM)875,760875,7600$15.95M$13.44M0.76%-$2.50M
Savara Inc.(SVRA)2,512,1532,512,1530$15.47M$12.96M0.74%-$2.51M
Hemab Therapeutics Hldgs Inc138,030420,000+281,970$5.07M$12.95M0.73%+$7.88M
Cogent Biosciences, Inc.NOTE 1 625 11 1(COGT)000$13.65M$12.05M0.68%-$1.60M
Climb Bio, Inc.(CLYM)972,000972,0000$12.67M$11.15M0.63%-$1.53M
ImmunityBio, Inc.(IBRX)01,180,000+1,180,000$0$11.14M0.63%+$11.14M
Beam Therapeutics Inc.(BEAM)0450,000+450,000$0$11.00M0.62%+$11.00M
Perspective Therapeutics, Inc.(CATX)4,214,5823,988,744-225,838$14.37M$10.97M0.62%-$3.40M
Jade Biosciences Inc840,350760,350-80,000$18.67M$10.68M0.61%-$7.99M
Prelude Therapeutics Incorporated(PRLD)02,600,000+2,600,000$0$10.17M0.58%+$10.17M
CRISPR Therapeutics AGNAMEN AKT(CRSP)100,000175,000+75,000$5.45M$9.68M0.55%+$4.23M
Veradermics, Incorporated(MANE)100,00079,400-20,600$12.29M$9.63M0.55%-$2.67M
Establishment Labs Holdings Inc.(ESTA)148,013149,779+1,766$12.70M$9.61M0.55%-$3.09M
Amylyx Pharmaceuticals, Inc.(AMLX)98,999300,000+201,001$1.78M$8.73M0.50%+$6.95M
Korsana Biosciences Inc0263,106+263,106$0$8.42M0.48%+$8.42M
Proqr Thrapeutics N VSHS EURO
SHS EURO
5,543,9364,970,074-573,862$10.31M$8.25M0.47%-$2.06M
Vera Therapeutics, Inc.CL A(VERA)250,000250,0000$10.73M$8.07M0.46%-$2.65M
Damora Therapeutics Inc0375,000+375,000$0$7.98M0.45%+$7.98M
Research Alliance Corp IiiCL A370,000735,538+365,538$3.96M$7.97M0.45%+$4.01M
Sol-Gel Technologies LtdSHS NEW
SHS NEW
84,900105,000+20,100$6.29M$7.80M0.44%+$1.50M
Celcuity IncNOTE 0 250 8 0000$2.28M$7.75M0.44%+$5.47M
IDEAYA Biosciences, Inc.(IDYA)400,000200,000-200,000$14.91M$7.68M0.44%-$7.22M
Anteris Technologies Global Corp.(AVR)912,397912,3970$8.99M$7.09M0.40%-$1.90M
Aktis Oncology, Inc.(AKTS)0350,000+350,000$0$6.81M0.39%+$6.81M
Enliven Therapeutics Inc500,000148,000-352,000$25.38M$6.78M0.38%-$18.59M
Newamsterdam Pharma Company
ORDINARY SHARES
275,000275,0000$9.32M$6.69M0.38%-$2.63M
Helix Acquisition Corp. IIICL A(HLXC)1,250,000625,000-625,000$13.30M$6.64M0.38%-$6.66M
X4 Pharmaceuticals, Inc.(XFOR)145,0002,062,500+1,917,500$677.1K$5.98M0.34%+$5.30M
Korro Bio, Inc.(KRRO)706,904531,904-175,000$9.32M$5.27M0.30%-$4.05M
Viridian Therapeutics, Inc.(VRDN)250,000250,0000$4.59M$5.15M0.29%+$555.0K
Silence Therapeutics plcADS(SLN)0450,000+450,000$0$4.92M0.28%+$4.92M
iBio, Inc.(IBIO)4,007,8814,130,427+122,546$7.01M$4.87M0.28%-$2.14M
Taysha Gene Therapies, Inc.(TSHA)1,750,0001,000,000-750,000$11.92M$4.87M0.28%-$7.05M
SAB Biotherapeutics, Inc.(SABS)1,525,0001,525,0000$5.95M$4.83M0.27%-$1.11M
Opus Genetics, Inc.(IRD)0900,000+900,000$0$4.36M0.25%+$4.36M
Faeth Therapeutics, Inc.(FTH)144,404144,4040$3.61M$4.29M0.24%+$684.5K
Equillium, Inc.(EQ)4,100,0002,613,954-1,486,046$13.12M$4.25M0.24%-$8.87M
Intellia Therapeutics, Inc.(NTLA)0350,000+350,000$0$4.22M0.24%+$4.22M
Latigo Biotherapeutics Inc0250,000+250,000$0$4.17M0.24%+$4.17M
Rezolute, Inc.(RZLT)1,000,0001,000,0000$5.20M$4.14M0.23%-$1.06M
Ark Etf TrGENOMIC REV ETF
GENOMIC REV ETF
074,900+74,900$0$4.06M0.23%+$4.06M
Precision BioSciences, Inc.(DTIL)646,576646,5760$5.08M$4.05M0.23%-$1.03M
Amanat Acquisition CorpCL A375,000375,0000$3.81M$4.00M0.23%+$195.0K
COMPASS Pathways plcADS(CMPS)301,183301,1830$4.26M$3.75M0.21%-$515.0K
Rainier Acquisition CorpUNIT 08 24 20310364,957+364,957$0$3.72M0.21%+$3.72M
MacroGenics, Inc.(MGNX)1,216,606953,979-262,627$5.62M$3.68M0.21%-$1.94M
Research Alliance Corp IvCL A0300,000+300,000$0$3.60M0.20%+$3.60M
Immunovant, Inc.(IMVT)100,000100,0000$3.85M$3.38M0.19%-$475.0K
Anaptysbio Inc826,10966,464-759,645$55.76M$3.34M0.19%-$52.42M
Zura Bio LimitedCL A(ZURA)1,464,303800,000-664,303$8.64M$3.33M0.19%-$5.31M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
245,000245,0000$5.34M$3.31M0.19%-$2.04M
Verrica Pharmaceuticals Inc.(VRCA)707,338688,654-18,684$4.33M$3.30M0.19%-$1.03M
ArriVent BioPharma, Inc.(AVBP)125,000100,000-25,000$4.34M$3.03M0.17%-$1.31M
MBX Biosciences, Inc.(MBX)75,00050,000-25,000$4.14M$2.93M0.17%-$1.21M
PMV Pharmaceuticals, Inc.(PMVP)01,750,000+1,750,000$0$2.92M0.17%+$2.92M
Solid Biosciences Inc0400,000+400,000$0$2.89M0.16%+$2.89M
Oaktree Acquisition Corp IiiUNIT 10 04 2029
UNIT 10/04/2029
250,000250,0000$2.75M$2.72M0.15%-$27.5K
Entera Bio Ltd.SHS(ENTX)0934,412+934,412$0$2.72M0.15%+$2.72M
Neumora Therapeutics, Inc.(NMRA)1,070,6514,500,000+3,429,349$1.82M$2.68M0.15%+$862.8K
Tcgx Acquisition CorpCL A0200,000+200,000$0$2.50M0.14%+$2.50M
Adlai Nortye Group Ltd.ADS(ANL)153,847153,8470$1.77M$2.46M0.14%+$692.3K
Eikon Therapeutics, Inc.(EIKN)98,001298,001+200,000$1.28M$2.40M0.14%+$1.12M
Jatt Iii Acquisition Corp0211,993+211,993$0$2.34M0.13%+$2.34M
Jatt Ii Acquisition Corp200,000200,0000$2.27M$2.25M0.13%-$23.0K
Spero Therapeutics, Inc.(SPRO)01,300,000+1,300,000$0$1.57M0.09%+$1.57M
Page 1 of 2
Affinity Asset Advisors, LLC — 13F Holdings — Q3 2026 | TickerTrail